Week 4 - L10 - Precision Genetic Engineering: The Cre-Lox System and CRISPR Integration
Fundamentals of the Cre-Lox Recombination System
The Cre-Lox system is a specialized genetic tool used primarily for creating conditional knockouts in laboratory mice.
The system functions by conditionally excising specific genetic material through the action of a site-specific recombinase enzyme.
This mechanism allows for the targeted removal of a gene of interest exclusively in specific cell types or under specific conditions, rather than a global knockout throughout the entire organism.
Component Requirements: The Floxed Mouse and Cre Mouse
Executing a conditional knockout requires the generation and mating of two distinct transgenic mouse lines.
The Floxed Mouse:
In this mouse line, the gene of interest is engineered to be surrounded by two sequence elements called LOX P sites.
The term "floxed" is a portmanteau for "flanked by LOX P."
LOX P sites are specific DNA sequences that must be oriented in the same direction (tandem repeats) to facilitate the excision of the intervening genetic material.
The Cre Recombinase Mouse:
This mouse line contains the Cre recombinase gene, which encodes the enzyme responsible for recognizing and acting upon the LOX P sites.
The expression of the Cre gene is placed under the control of a specific enhancer or promoter (designated as Enhancer or Promoter ).
The choice of enhancer or promoter dictates precisely where in the mouse (i.e., in which tissues or cell types) the Cre recombinase will be expressed.
The Mechanism of Gene Excision
To produce a knockout, the floxed mouse is mated with the Cre recombinase mouse to create an generation. Subsequent crossing may be required to achieve a homozygous floxed state.
In cells where the specific enhancer is active, the Cre recombinase protein is produced.
The Cre recombinase enzyme binds to the two LOX P sites flanking the gene of interest.
The interaction of the enzyme with the LOX P sites induces the DNA to form a loop structure.
Cre mediates a recombination event that effectively merges the two LOX P sites into one, causing the intervening DNA (the gene of interest) to be "looped out" or excised from the chromosome.
Once the gene is excised in a circular form, it has no mechanism for re-insertion or replication and is subsequentally lost as the cell divides. This renders the gene permanently non-functional in that specific cell lineage.
Liver-Specific Knockout: A Case Study
Consider a scenario involving Gene , which is hypothesized to have a critical function in the liver but is also essential for embryonic development.
A global knockout of Gene would result in embryonic lethality, preventing the study of its function in the adult liver.
To solve this, a conditional knockout is designed:
Cre Source: A mouse is used where Cre recombinase is under the control of the albumin enhancer. Albumin is a protein produced specifically in the liver; therefore, Cre production is restricted to liver cells.
Floxed Source: A transgenic mouse is used where Gene is flanked by LOX P sites on both chromosomes.
The Breeding Process:
The first cross produces offspring that are heterozygous for the floxed Gene and carry the albumin-Cre transgene.
In the non-liver tissues of these mice, the Cre protein is not produced, and the cells maintain two functional copies of Gene .
In the liver, the albumin enhancer triggers Cre production, which excises one copy of Gene . This creates a liver-specific heterozygote.
Achieving Complete Knockout:
To observe a mutant phenotype, both copies of Gene must be removed. This is achieved by crossing the heterozygotes with another floxed mouse to obtain progeny that possess the Cre transgene and are homozygous for the floxed Gene .
In these specific mice, the Cre recombinase excise both copies of the gene within the liver, allowing researchers to observe the mutant phenotype in a living adult mouse.
Temporal Control via Inducible Cre-Lox Systems
Beyond spatial (tissue-specific) control, the system can be modified to provide temporal (time-specific) control.
This is achieved through an inducible version of Cre, such as a Cre recombinase fused to a specialized receptor.
In this system, Cre is expressed in the target cells (e.g., liver) but remains sequestered or inactive and cannot bind to LOX P sites.
Functionality is only triggered by the administration of an exogenous agonist, such as tamoxifen.
When tamoxifen is introduced, it binds to the receptor attached to Cre, allowing the Cre recombinase to become functional, bind to LOX P sites, and excise the target gene.
This allows researchers to choose the exact developmental stage or age at which the gene knockout occurs.
Integration with CRISPR Cas Technology
The CRISPR Cas system provides a highly efficient method for generating the various components needed for Cre-Lox studies using a single RNA molecule and the Cas protein.
Indel Mutations: Without providing homologous DNA for repair, CRISPR Cas can create double-strand breaks that are repaired via non-homologous end joining (NHEJ), resulting in insertions or deletions (indels) that create standard knockout lines.
Precise Substitutions: By providing a target DNA sequence for homologous repair (Homology Directed Repair/HDR), CRISPR Cas can be used to introduce specific single amino acid substitutions to model pathogenic variants found in human homologs.
Generating Floxed Alleles: CRISPR Cas can be used to facilitate the creation of the floxed mouse itself. By using guide and tracer RNAs to target specific introns or exons, researchers can provide a repair template that contains an exon flanked by LOX P sites. Once the Cas protein cuts the genomic DNA, the repair process integrates the LOX P sites, efficiently "floxing" the gene for subsequent use with Cre recombinase.